Skip to main content
logo
Cambium Bio Limited (ASX:CMB)
Australia flag Australia · Delayed Price · Currency is AUD
0.5000
+0.0050 (1.01%)
Sep 18, 2026, 1:20 PM AEST

Cambium Bio Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23
Revenue
1.231.230.770.181.01
Revenue Growth
83.26%58.17%337.80%-82.55%-
Gross Profit
1.041.040.570.131.01
Operating Income
-3.77-3.77-4.19-1.71-1.2
Net Income
-4.1-4.1-3.84-2.26-1.69
Earnings Per Share
-0.17-0.17-0.21-0.54-0.55
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23
Cash & Investments
1.121.120.172.860.3
Total Debt
0.150.150.480.470.35
Net Cash (Debt)
0.970.97-0.322.4-0.04
Net Cash Growth
167.88%----
Net Cash Per Share
0.040.04-0.020.57-0.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23
Operating Cash Flow
-2.81-2.81-5.24-0.16-0.66
Capital Expenditures
-0-0-0.01--
Free Cash Flow
-2.81-2.81-5.25-0.16-0.66
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23
Gross Margin
84.47%84.47%74.09%72.59%100.00%
Operating Margin
-307.87%-307.87%-540.83%-964.22%-118.76%
Pretax Margin
-334.20%-334.20%-496.11%-1274.48%-166.33%
Profit Margin
-334.20%-334.20%-496.11%-1274.48%-166.33%
FCF Margin
-229.25%-229.25%-677.17%-88.06%-65.12%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23
PS Ratio
12.019.594.9633.70-